Fate Therapeutics, Inc.FATENASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank79
3Y CAGR-24.7%
Year-over-Year Change
Net other income and expenses outside core operations
3Y CAGR
-24.7%/yr
vs +171.1%/yr prior
Acceleration
-195.7pp
Decelerating
Percentile
P79
Within normal range
vs 3Y Ago
0.4x
Contraction
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $11.39M | -52.6% |
| 2024 | $24.01M | -18.8% |
| 2023 | $29.58M | +10.9% |
| 2022 | $26.66M | +450.6% |
| 2021 | $4.84M | +110.7% |
| 2020 | $-45.30M | -1857.3% |
| 2019 | $2.58M | +421.9% |
| 2018 | $494000.00 | +159.7% |
| 2017 | $-827000.00 | +44.8% |
| 2016 | $-1.50M | - |